Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network
Joan Puig-Barberà,Ainara Mira-Iglesias,Elena Burtseva,Benjamin J Cowling,Unal Serhat,Guillermo Miguel Ruiz-Palacios,Odile Launay,Jan Kyncl,Parvaiz Koul,Marilda M Siqueira,Anna Sominina,Global Influenza Hospital Surveillance Network,A Bagci Bosi,A Goldstein,A Mira-Iglesias,A Sominina,B Costa-Caetano,B Cowling,B Guglieri-López,C El Guerche-Seblain,C Mahé,C Vlasich,E Burtseva,F Luzhao,F Pradel,F E Moura,F X López-Labrador,G M Ruiz-Palacios,H Schwarz-Chávarri,J Díez-Domingo,J Gurlichova,J Kyncl,J Mollar-Maseres,J Puig-Barberà,K Mubashir,K Stolyarov,L Kisteneva,L Kolobukhina,M Akcay Ciblak,M Carballido-Fernández,M de Los Ángeles-Gutiérrez,M Durusu Tanriover,M Pisareva,M Siqueira,M Tortajada-Girbés,M L Guerrero-Almeida,O Afanasieva,O Launay,P Cervantes,P Koul,P Loulergue,S Raboni,S Trushakova,S Unal,V Baselga-Moreno,V Picot,W Peng,Y Qin,Y Hongjie,Z Lesieur,Z Mandakova
DOI: https://doi.org/10.1186/s12879-019-4017-0
2019-05-14
Abstract:Background: The Global Influenza Hospital Surveillance Network is an international platform whose primary objective is to study severe cases of influenza requiring hospitalization. Methods: During the 2015-2016 influenza season, 11 sites in the Global Influenza Hospital Surveillance Network in nine countries (Russian Federation, Czech Republic, Turkey, France, China, Spain, Mexico, India, and Brazil) participated in a prospective, active-surveillance, hospital-based epidemiological study. Influenza infection was confirmed by reverse transcription-polymerase chain reaction. Influenza vaccine effectiveness (IVE) against laboratory-confirmed influenza was estimated using a test-negative approach. Results: 9882 patients with laboratory results were included of which 2415 (24.4%) were positive for influenza, including 1415 (14.3%) for A(H1N1)pdm09, 235 (2.4%) for A(H3N2), 180 (1.8%) for A not subtyped, 45 (0.5%) for B/Yamagata-lineage, 532 (5.4%) for B/Victoria-lineage, and 33 (0.3%) for B not subtyped. Of included admissions, 39% were < 5 years of age and 67% had no underlying conditions. The odds of being admitted with influenza were higher among pregnant than non-pregnant women (odds ratio, 2.82 [95% confidence interval (CI), 1.90 to 4.19]). Adjusted IVE against influenza-related hospitalization was 16.3% (95% CI, 0.4 to 29.7). Among patients targeted for influenza vaccination, adjusted IVE against hospital admission with influenza was 16.2% (95% CI, - 3.6 to 32.2) overall, 23.0% (95% CI, - 3.3 to 42.6) against A(H1N1)pdm09, and - 25.6% (95% CI, - 86.3 to 15.4) against B/Victoria lineage. Conclusions: The 2015-2016 influenza season was dominated by A(H1N1)pdm09 and B/Victoria-lineage. Hospitalization with influenza often occurred in healthy and young individuals, and pregnant women were at increased risk of influenza-related hospitalization. Influenza vaccines provided low to moderate protection against hospitalization with influenza and no protection against the predominant circulating B lineage, highlighting the need for more effective and broader influenza vaccines.